Physician
Michiana Hematology-Oncology P C
Michiana Hematology-Oncology P C was paid $2.97M by Medicaid between Jan 2018 and Nov 2024, across 35 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoMICHIANA HEMATOLOGY-ONCOLOGY P C
MISHAWAKA, IN 46545
MISHAWAKA, IN 46545
33aNPI1619970183assigned 05/27/2005
33bProvider typeHematology & Oncology Physician
28Total paid$2.97M
24GClaims91,811
24DCodes billed35
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Indiana
Rank by total paid#2 of 26
Median peer was paid$47K
This provider vs. median63×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,681 | $181K | |
| 2019 | 17,489 | $466K | |
| 2020 | 17,235 | $478K | |
| 2021 | 13,171 | $493K | |
| 2022 | 12,361 | $520K | |
| 2023 | 10,543 | $510K | |
| 2024incomplete | 6,331 | $320K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 18,444 | 14,875 | $926K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 26,276 | 21,175 | $850K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 22% | 15,517 | 8,678 | $643K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.4% | 9,688 | 5,415 | $132K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 2.5% | 418 | 38 | $75K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.5% | 630 | 480 | $46K |
| J0897 | Injection, denosumab, 1 mg | 1.4% | 106 | 92 | $42K |
| 77427 | 1.2% | 502 | 202 | $36K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 5,019 | 3,372 | $34K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1.0% | 87 | 61 | $31K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,967 | 1,670 | $28K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,310 | 314 | $19K |
23 more codes
| 77336 | <1% | 443 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 263 | $12K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 870 | $12K |
| 99205 | Prolong outpt/office vis | <1% | 77 | $11K |
| 96417 | <1% | 653 | $9K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 169 | $8K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 192 | $8K |
| 77334 | <1% | 55 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 434 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 61 | $5K |
| 96415 | <1% | 399 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 144 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,945 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 26 | $2K |
| 77263 | <1% | 14 | $1K | |
| 96367 | <1% | 191 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 65 | $1K |
| 90688 | <1% | 32 | $187.96 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 225 | $48.78 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 21 | $5.89 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 422 | $2.96 |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 75 | $0.00 |
| 96401 | 0% | 71 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANSARI, BILAL (CO-OWNER)